Dr. Ricky Chiu is the CEO, co-founder and lead inventor of Phase Diagnostics’ underlying technology. Prior to Phase Diagnostics, he was a former project manager at BMC (now Alere Inc.), where he took several rapid point-of-care diagnostics from concept to market; amongst his most successful products is OratectXP, the first FDA approved drug-of-abuse diagnostic that utilized oral fluid. Dr. Chiu co-founded the U.S. company, Phase Diagnostics Inc, after receiving his PhD in Bioengineering at the University of California, Los Angeles. Since then he has secured millions of dollars in grant funding and has closed another million dollars Seed round of private equity financing. Phase Diagnostics has now grown to 18 employees and is expecting to continue rapid expansion in 2018. In addition, Dr. Chiu is establishing a foothold in the Asia Pacific by launching a Biotech research, manufacturing and distribution company, Phase Scientific International Limited, in Hong Kong and three other offices in mainland China. Within a year, Dr. Chiu has taken his platform diagnostic technology from proof-of-concept to working prototype and is targeting a first product launch of their lead product in Hong Kong and the United States next year.